
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















Analysis Of Prescription Compliance with WHO and ICD Protocols for Emerging, Re-Emerging, Infectious, and Non-Communicable Diseases in Ghana (A cross-sectional study)
Author(s) | Dr. Ibrahim Ibn Saana, Dr. Charles Ofei-Palm, Dr. Daniel N.A. Ankrah, Mr. Isaiah Sagoe, Dr. Daniel Amaning Danquah, Ms. Olga Awuni, Mr. Lawer Lano, Ms. Ashong Juliana, Mr. Theophilus O. Agyeman |
---|---|
Country | Ghana |
Abstract | Background: Worldwide, there is a growing concern about the increasing resistance to antibiotics used to treat common infectious diseases. In the current global crisis of bacterial resistance, antimicrobial stewardship programs are crucial. The impact of prescribing for emerging, reemerging, contagious, and non-communicable diseases on the appropriateness, quality, and quantity of antibiotic use within our hospital settings is of utmost importance for ensuring quality care. Studies have shown that specialist intervention was associated with a significant improvement in the appropriateness and compliance with guidelines and standards of antibiotic prescribing as compared with prescriptions without any specialist input Aim: This paper aims to evaluate compliance with WHO prescribing guidelines for the stated conditions and to assess their ICD adherence. It also analyzes trends in prescriptions received from specialists in the context of emerging, re-emerging, infectious, and non-communicable diseases, highlighting current challenges. Recommendations have been sent to the national TB program for consideration and attention. Methodology: Information about all patients who presented prescriptions at the pharmacy between January 2019 and June 10, 2022, was recorded. Patients’ sociodemographic and prescription histories were retrieved using secondary data from the pharmacy register. A total of 45 non-tuberculous prescriptions were classified into nine disease categories. Descriptive statistics were used to analyze the data using Stata, by the World Health Organization (WHO) guidelines, International Classification of Diseases (ICD), and Standard Treatment Guidelines for Prescribing. The results are presented accordingly. Results: Out of the total number of patients seen over the period, 6728 had tuberculous prescriptions while 45 prescriptions (persons) were for non-tuberculous (prescriptions. The median age was 45 years (range,22-83). 71% of males and 29% of females. 4% in the first quarter of 2022. 36% in 2021 and 58% in 20202% of the non-tuberculous prescriptions were received in 2019. Conclusion: 95%, which forms the majority, are non-conforming cases. A smaller portion is conditionally conforming. No diseases were fully conforming, indicating areas for clinical protocol improvement |
Keywords | : Emerging infectious disease, WHO Standards, Prescriptions, ICD classifications, non-tuberculosis, Medications |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 4, July-August 2025 |
Published On | 2025-08-06 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.49282 |
Short DOI | https://doi.org/g9whxt |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
